Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-04-29
1988-09-20
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 95, 424101, 514 2, 514 8, 530397, 530399, A61K 3526
Patent
active
047725885
ABSTRACT:
A course of a parasitic, e.g. protozoal, infection is combated by administering to the host an immunomodulating effective amount of a calf thymus hormone extract.
REFERENCES:
patent: 4010148 (1977-03-01), Goldstein
patent: 4128637 (1978-12-01), Naylor et al.
patent: 4133804 (1979-01-01), Bach et al.
patent: 4239498 (1980-12-01), Rule
patent: 4250084 (1981-02-01), Trainin
patent: 4521407 (1985-06-01), Pelham et al.
patent: 4571336 (1986-02-01), Houck et al.
patent: 4576696 (1986-03-01), Oertli
Chem. Abstracts, 94 (1981), 81996v, Falchetti et al.
Abstracts of 1976 3rd European Immunology Meeting on Aug. 25-27, 1976.
Falchetti et al., "Pharmacological and Biological Properties of a Calf Thymus Extract (TP-1)", Drugs Exptl. Clin. Res. 3 (2) 39-47 (1977).
Bergesi et al., "Chemical Characterization and Biological Activity of a New Thymic Extract", Folia Aleergol Immunol. Clin. 21:201, 1977.
Falchetti et al., "Bioassay for Thymic Extracts: Guinea Pig Spleen Lymphocytes-Rabbit Red Blood Cells Rosette Method", Cancer Biochem. Biophys., 1979, vol. 4, pp. 69-74.
Istituto Farmacologico Serono S.p.A.
Schain Howard E.
LandOfFree
Treatment of parasitic diseases with calf thymus extract does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of parasitic diseases with calf thymus extract, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of parasitic diseases with calf thymus extract will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1748589